Reuters logo
FTC, states settle with Mallinckrodt over Acthar
January 18, 2017 / 8:59 PM / a year ago

FTC, states settle with Mallinckrodt over Acthar

WASHINGTON, Jan 18 (Reuters) - Mallinckrodt Plc, which bought Questcor Pharmaceuticals in 2014, has agreed to pay $100 million to settle allegations that Questcor broke antitrust law in pricing its multiple sclerosis drug H.P. Acthar Gel, the Federal Trade Commission said on Wednesday. (Reporting by Diane Bartz; Editing by Sandra Maler)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below